Clinical trial
A Double-Blind, Placebo-Controlled Trial of the Effectiveness of Memantine in Treating Cocaine Dependence
NCT00134901 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Trial of the Effectiveness of Memantine in Treating Cocaine Dependence
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- May 31, 2007
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.